Fig. 3. The proportion of patients those achieved 2 or less in Frequency, Intensity, and Burden of Side Effects Ratings sub-scores at the end of treatment.

PGATx, pharmacogenomic-based antidepressant treatment; TAU, treatment as usual.

Clinical Psychopharmacology and Neuroscience 2018;16:469~480 https://doi.org/10.9758/cpn.2018.16.4.469

© Clin Psychopharmacol Neurosci